Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade D 22.91 -1.12% -0.26
BHC closed down 1.12 percent on Wednesday, July 17, 2019, on 73 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BHC trend table...

Date Alert Name Type % Chg
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -1.12%
Inside Day Range Contraction -1.12%
Down 3 Days in a Row Weakness -1.12%
Down 4 Days in a Row Weakness -1.12%
Down 5 Days in a Row Weakness -1.12%
Oversold Stochastic Weakness -1.12%

Older signals for BHC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Biotechnology Life Sciences Laser Organ Systems S&P/Tsx 60 Index Psoriasis Medical Devices Acne Specialty Drugs Ulcerative Colitis Atopic Dermatitis Diarrhea Irritable Bowel Syndrome Hair Removal Generic Pharmaceuticals Over The Counter Products Salix Pharmaceuticals Bausch Health Eye Health Products
Is BHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.45
52 Week Low 17.2
Average Volume 3,584,934
200-Day Moving Average 23.8492
50-Day Moving Average 23.6308
20-Day Moving Average 24.3615
10-Day Moving Average 24.274
Average True Range 0.7381
ADX 22.48
+DI 21.3463
-DI 29.4503
Chandelier Exit (Long, 3 ATRs ) 23.6857
Chandelier Exit (Short, 3 ATRs ) 23.6643
Upper Bollinger Band 26.0448
Lower Bollinger Band 22.6782
Percent B (%b) 0.07
BandWidth 13.819346
MACD Line 0.0627
MACD Signal Line 0.3252
MACD Histogram -0.2625
Fundamentals Value
Market Cap 7.99 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -7.01
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.75
Resistance 3 (R3) 23.78 23.54 23.61
Resistance 2 (R2) 23.54 23.32 23.52 23.56
Resistance 1 (R1) 23.22 23.19 23.10 23.19 23.52
Pivot Point 22.98 22.98 22.92 22.96 22.98
Support 1 (S1) 22.66 22.76 22.54 22.63 22.30
Support 2 (S2) 22.42 22.63 22.40 22.26
Support 3 (S3) 22.10 22.42 22.21
Support 4 (S4) 22.07